Deepwater Horizon/BP Oil Spill: Re-opening Decisions, Test Results, and Post Re-opening Surveillance Data

• Water column data
  • Water Column data collected from aircrafts
  • Water Column data collected from ships
  • Water Column data collected from gliders and floats
    
    
• April 19, 2011 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3 (sample locations)
    • Attachment 4a (Seafood testing data)
    • Attachment 4b (Seafood testing data)
    • Attachment 5 (Metabolism of PAHs by Teleost Fish)
    • FDA Concurrence Letter
      
      
• February 2, 2011 Re-Opening (Royal Red Shrimp)
  • Press Release
  • Sample Locations (with trawl numbers)
  • Sample Locations
  • Seafood Testing data (Chemical Analysis)
  • Seafood Testing data (Sensory and Detailed Chemistry)
  • Summary of the Royal Red Shrimp Data
  • Metabolism of PAHs by Teleost Fish
    
    
• November 15, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3a (sample locations)
    • Attachment 3b (sample locations)
    • Attachment 4a (Seafood testing data)
    • Attachment 4b (Seafood testing data)
    • Attachment 5 (Metabolism of PAHs by Teleost Fish)
    • FDA Concurrence Letter (a)
    • FDA Concurrence Letter (b)
    • Results of post reopening sampling (summary)
    • Results of post reopening sampling (test results) - Updated 13 Apr 2011
      
      
• October 29, 2010 Dispersant Test Announced
  • FDA Letter Regarding Levels of Concern
  • DOSS Table 1 Federal Reopen
  • DOSS Table 2 Post Reopen
  • DOSS Table 3 Dockside
  • DOSS Table 4 State Reopen
  • Press Release
    
    
• October 22, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3 (sample locations)
    • Attachment 4 (Seafood testing data)
    • Attachment 5 (Metabolism of PAHs by Teleost Fish)
    • FDA Concurrence Letter
    • Results of post reopening sampling (summary)
    • Results of post reopening sampling (test results) - Updated 13 Apr 2011
      
      
• October 15, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3 (sample locations)
    • Attachment 4 (Seafood testing data)
    • Attachment 5 (Metabolism of PAHs by Teleost Fish)
    • FDA Concurrence Letter
    • Results of post reopening sampling (summary)
    • Results of post reopening sampling (test results) - Updated 13 Apr 2011
      
      
• October 5, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3 (sample locations)
    • Attachment 4 (Seafood testing data)
    • Attachment 5 (Metabolism of PAHs by Teleost Fish)
    • FDA Concurrence Letter
    • Results of post reopening sampling (summary)
    • Results of post reopening sampling (test results) - Updated 13 Apr 2011
      
      
• October 1, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3 (sample locations)
    • Attachment 4a (Seafood testing data)
    • Attachment 4b (Seafood testing data)
    • Attachment 5 (Metabolism of PAHs by Teleost Fish)
    • FDA Concurrence Letter
    • Results of post reopening sampling (summary)
    • Results of post reopening sampling (test results) - Updated 12 Apr 2011
      
      
• September 21, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3 (sample locations)
    • Attachment 4 (Seafood testing data)
    • Attachment 5 (Metabolism of PAHs by Teleost Fish)
    • FDA Concurrence Letter
    • NOAA Press Release
    • Results of post reopening sampling (summary)
    • Results of post reopening sampling (test results) - Updated 13 Apr 2011
      
      
• September 3, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3 (sample locations)
    • Attachment 4 (Seafood testing data)
    • Attachment 5 (Metabolism of PAHs by Teleost Fish)
    • FDA Concurrence Letter
    • Results of post reopening sampling (summary)
    • Results of post reopening sampling (test results) - Updated 13 Apr 2011
      
      
• September 2, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
  • Appendix A: Quality Assurance/Quality Control Assessment -- Inconclusive Sensory Samples
  • Attachment 1 (NOAA-FDA Opening Protocol)
  • Attachment 2 (Map of re-opened area)
  • Attachment 3 (sample locations)
  • Attachment 4 (Seafood testing data)
  • Attachment 5 (Metabolism of PAHs by Teleost Fish)
  • FDA Concurrence Letter
  • NOAA Press Release
  • Results of post reopening sampling (summary)
  • Results of post reopening sampling (test results) - Updated 13 Apr 2011
    
    
• August 27, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3 (sample locations)
    • Attachment 4 (Seafood testing data)
    • Attachment 5 (Metabolism of PAHs by Teleost Fish)
    • Explanation of Seafood testing data
    • FDA Concurrence Letter
    • Results of post reopening sampling (summary)
    • Results of post reopening sampling (test results) - Updated 13 Apr 2011
      
      
• August 10, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3 (sample locations)
    • Attachment 4 (Seafood testing data)
    • Attachment 5 (Metabolism of PAHs by Teleost Fish)
    • Explanation of Seafood testing data
    • FDA Concurrence Letter
    • NOAA Press Release
    • Results of post reopening sampling (summary)
    • Results of post reopening sampling (test results) - Updated 13 Apr 2011
      
      
• July 22, 2010 Re-Opening
  • Letter to the U.S. Food and Drug Administration with rationale for re-opening
    • Attachment 1 (NOAA-FDA Opening Protocol)
    • Attachment 2 (Map of re-opened area)
    • Attachment 3 (sample locations)
    • Attachment 3 inset (sample locations)
    • Attachment 4a Seafood testing data
    • Attachment 4b Seafood testing data
    • Explanation of Seafood testing data
    • Metabolism of PAHs by Teleost Fish
    • FDA Concurrence Letter
    • NOAA Press release
    • Results of post reopening sampling (summary) - Updated 13 Apr 2011
    • Results of post reopening sampling (test results) - Updated 13 Apr 2011

Seafood Surveillance Data
(April 13, 2011)

The small gray dots show all stations sampled from April 28, 2010 through January 15, 2011. The larger blue dots show reopened areas sampled from March 6 - June 15, 2011, and the red dots show stations sampled for reopening the final closed area nearest the well. For more information, click here.